Table 4 Cox proportional hazards regression analysis of survival in all 208 patients.

From: Postoperative radiotherapy to the neck for pN1 status HNSCC patients after neck dissection

Characteristic

RRFS

OS

DMFS

Univariable

Multivariable

Univariable

Multivariable

Univariable

Multivariable

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

Age

1.01 (1.00–1.03)

.020

1.01 (1.00–1.03)

.041

1.02 (1.01–1.03)

.004

1.02 (1.01–1.03)

.006

1.02 (1.01–1.03)

.004

1.02 (1.01–1.03)

.007

Sex

0.98 (0.71–1.35)

.882

0.96 (0.63–1.47)

.863

0.96 (0.70–1.33)

.824

0.94 (0.61–1.44)

.765

1.01 (0.73–1.40)

.949

1.06 (0.69–1.62)

.800

Cigarette use

1.03 (0.78–1.36)

.840

1.24 (0.80–1.91)

.331

1.02 (0.77–1.34)

.909

1.28 (0.82–1.99)

.279

1.06 (0.81–1.40)

.667

1.35 (0.87–2.12)

.183

Alcohol consumption

0.85 (0.64–1.13)

.262

0.74 (0.50–1.11)

.150

0.84 (0.63–1.11)

.212

0.72 (0.48–1.08)

.114

0.88 (0.66–1.17)

.371

0.77 (0.51–1.15)

.766

pT status

 

.586

 

.694

 

.446

 

.541

 

.370

 

.517

pT1

0.80 (0.50–1.30)

.375

0.85 (0.51–1.39)

.508

0.69 (0.43–1.12)

.132

0.71 (0.43–1.17)

.180

0.71 (0.44–1.14)

.157

0.74 (0.45–1.21)

.227

pT2

0.83 (0.56–1.22)

.347

0.83 (0.55–1.24)

.362

0.80 (0.54–1.18)

.266

0.79 (0.52–1.43)

.245

0.83 (0.56–1.23)

.354

0.82 (0.55–1.24)

.351

pT3

1.02 (0.64–1.64)

.927

1.01 (0.62–1.64)

.966

0.91 (0.57–1.46)

.693

0.88 (0.55–1.43)

.614

1.02 (0.64–1.64)

.928

1.00 (0.62–1.61)

.993

pT4

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Primary site

 

.387

 

.348

 

.221

 

.375

 

.144

 

.332

Oral cavity

0.81 (0.57–1.16)

.252

0.78 (0.47–1.28)

.323

0.79 (0.55–1.12)

.183

0.84 (0.51–1.39)

.501

0.75 (0.54–1.07)

.112

0.79 (0.48–1.30)

.353

Oropharynx

0.99 (0.63–1.56)

.959

1.15 (0.71–1.88)

.577

1.03 (0.65–1.63)

.904

1.23 (0.75–2.01)

.416

1.00 (0.63–1.59)

.992

1.19 (0.73–1.94)

.494

Hypopharynx

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

High-risk factors in the primary site

 

.212

 

.309

 

.090

 

.150

 

.107

 

.222

Perineural invasion

0.31 (0.04–2.22)

.241

0.27 (0.04–2.03)

.204

0.21 (0.03–1.51)

.120

0.18 (0.02–1.38)

.100

0.24 (0.03–1.76)

.162

0.21 (0.03–1.59)

.131

Lymphovascular invasion

0.51 (0.05–5.61)

.578

0.38 (0.03–4.46)

.441

0.40 (0.04–4.45)

.455

0.29 (0.02–3.39)

.321

0.44 (0.04–4.84)

.498

0.29 (0.03–3.48)

.332

Positive margin

0.82 (0.08–7.91)

.862

0.63 (0.06–6.63)

.698

0.62 (0.06–6.03)

.681

0.47 (0.05–4.98)

.532

0.75 (0.08–7.30)

.806

0.51 (0.05–5.43)

.575

None

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

PORT to the neck

1.04 (0.78–1.38)

.784

1.26 (0.82–1.93)

.296

0.95 (0.72–1.26)

.725

1.11 (0.72–1.69)

.642

0.95 (0.72–1.26)

.717

1.15 (0.75–1.78)

.523

  1. RRFS regional recurrence-free survival, OS overall survival, DMFS distant metastasis-free survival, pT status pathologic tumor status, HR hazard ratio, CI confidence interval, NA not applicable.